p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus

Gastroenterology

Volumn 122, Issue 4, 2002, Pages 1113-1121

  Bian, YanSong ^a   Osterheld, MariaChiara ^a   Fontolliet, Charlotte ^a   Bosman, Fred T ^a   Benhattar, Jean ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

ALLELE; ARTICLE; BARRETT ESOPHAGUS; CDKN2A GENE; CHROMOSOME MICRODISSECTION; CONTROLLED STUDY; DISEASE COURSE; GENE LOCUS; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INTESTINE METAPLASIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; SINGLE STRAND CONFORMATION POLYMORPHISM; TISSUE FIXATION; TUMOR SUPPRESSOR GENE;

EID: 0036210281     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.32370     Document Type: Article

References (45)

1. Barrett's esophagus: Natural history, incidence, etiology and complications
2. Prevalence of metaplasia at the gastro-oesophageal junction
3. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue
4. Evolution of neoplastic cell lineages in Barrett oesophagus
5. Epigenetic patterns in the progression of esophageal adenocarcinoma
6. Cancer cell cycles
7. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin/cdk4
8. A cell cycle regulator potentially involved in the genesis of many tumor types
9. Retinoblastoma protein-dependent cell-cycle inhibition by the tumor suppressor p16
10. Overexpression of cyclin D1 enhances gene amplification
11. Frequent homozygous deletion at p16/cdkn2 in primary human tumors
12. Mutation frequency of the P16/CDKN2 gene in primary cancers in the upper digestive tract
13. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus
14. INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas
15. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus
16. 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers
17. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)
18. COBRA: A sensitive and quantitative DNA methylation assay
19. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
20. DNA methylation analysis: A review of current methodologies
21. Methylation-sensitive, single-strand conformation analysis (MS-SSCA): A rapid method to screen for and analyze methylation
22. Complex methylation patterns analyzed by single-strand conformation polymorphism
23. Promoter methylation analysis on microdissected paraffin-embedded tissues using bisulfite treatment and PCR-SSCP
24. Superficial flat-type early carcinoma of the stomach
25. Histopathology of reflux-induced esophageal and supraesophageal injuries
26. Microdissection by exclusion and DNA extraction for multiple PCR analyses from archival tissue sections
27. Analysis of the INK4a/ARF locus in non-Hodgkin's lymphomas using two new internal microsatellite markers
28. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
29. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma
30. INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene: A comparison of four commercial antibodies
31. An improved method for rapid screening of DNA mutations by nonradioactive single-strand conformation polymorphism procedure
32. INK4B methylation in acute myeloid leukemia
33. DNA methylation analysis using bisulfite treatment and PCR-single strand conformation polymorphism in colorectal cancer showing microsatellite instability
34. Low frequency of p16/CDKN2A methylation in sporadic melanoma: Comparative approaches for methylation analysis of primary tumors
35. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia
36. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas
37. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability
38. Mechanisms underlying losses of heterozygosity in human colorectal cancers
39. Genomic instability: First step to carcinogenesis
40. DNA methylation and chromosome instability in breast cancer cell lines
41. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas
42. Allelic loss involving the tumor suppressor genes APC and MCC and expression of the APC protein in the development of dysplasia and carcinoma in Barrett esophagus
43. Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies
44. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma
45. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma